Global Bioprinting Markets and Opportunities Report 2022: How the Major Bioprinting Companies are Designing their Marketing Strategies to Take their Share of the $1.2 Billion Industry
Saturday, February 4, 2023
DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Bioprinting: Markets and Opportunities" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Revenues from bioprinting are expected to reach almost $1.2 billion in 2028, compared with just $182 million today
The new report provides a realistic assessment of bioprinting's commercial future including an analysis of how the major bioprinting companies are designing their marketing strategies. In addition to the pure play bioprinting companies, the bioprinting sector is seeing involvement from major life science companies and 3D printing companies.
By 2028, the analyst expects almost 70 percent of the bioprinting industry to come from applications and service revenues. The new report claims that we are many years from transplanting printed organs. Nonetheless, bioprinting is finding a rapidly growing application in drug and cosmetics testing. Using printed tissues and organs avoids the need for animal testing and enables testing on printed tissue and organs that are realistic substitutes for the real thing.
Report Scope:
The analyst has been tracking the bioprinting industry for almost a decade and this is its third major bioprinting report. The report covers bioinks and bio-printing related applications, as well as the bioprinters themselves. Applications discussed in the report include drug discovery and testing, cosmetics testing, tissue and bone printing.
We also examine the long-term prospects for transplanting bioprinted organs. And there is a chapter on new directions for bioprinting including discussions on soft robotics, pill printing, and printed food.
There are now well over 100 firms in the bioprinting sector, but most of these companies have negligible revenues. Among the firms that are discussed in this report are 3DBio Therapeutics, 3D Systems/Systemic Bio, BICO (Cellink), Collplant, Cyfuse, EnvisionTEC/Desktop Metal, FluidForm, Inventia Life Science, Organovo Holdings, Poietis, Regamat, Rokit Healthcare and many others.
According to Lawrence Gasman, author of the report, "New applications are quickly emerging for bioprinting, and they are very much in line with important megatrends in healthcare - notably the trends towards personalized medicine and bringing care closer to the patient. For example, bioprinting can enable procedures such as skin grafting to be performed in a clinic rather than at specialized hospitals."
Report Highlights
-- Production-grade bioprinters and reproducible bioprinting applications
are coming to the fore. By 2031, R&D service revenues will clock up
almost $250 million in service/applications revenue for bioprinting, but
this will still only amount to 12 percent of total service/applications
revenues in the bioprinting industry.
-- The analyst expects technological innovation across the entire
bioprinting sector to accelerate. The new report points to three
developments in particular as areas of strong commercial potential. One
of these is the arrival of organs-on-a-chip, a product class that
bioprinting does much to enable. The report also predicts that
bioprinters will move beyond the currently dominant extrusion and inkjet
machines. Already as many as 20 novel ways of doing bioprinting are
emerging from leading labs and healthcare facilities worldwide. While
extrusion and inkjet bioprinters will account for well over 90 percent
of bioprinter revenues in 2022, but by 2031, 15 percent of bioprinter
revenues will come from printers based on entirely novel printing
technologies.
-- Another technical trend that is leading bioprinting forward
technologically and will improve costs to patients and expand
capabilities is the trend toward next-generation bioprinting platforms
that have greater capacities, automate much of the work, and integrate
medical functionality well beyond basic bioprinting. By 2031 the analyst
expects production grade bioprinters or biomanufacturing platforms
incorporating bioprinting to clock up around $100 million in revenues.
Key Topics Covered:
Chapter One: Overview
1.1 Background to Report: A Renaissance for Bioprinting?
1.2 Bioprinting: An Attractive Business Opportunity Going Forward
1.2.1 History and Prospects
1.2.2 Bioprinting Industry Structure
1.2.3 Evolution of the Bioprinting Industry
1.3 Geographical Diversity of Companies
1.4 Goal, Scope and Plan of this Report
1.5 Methodology of this Report
1.5.1 Forecasting Methodology and Assumptions
1.6 Key Points from this Chapter
Chapter Two: Bioprinting: Market Drivers and Market Challenges
2.1 Factors that Could Lead to the "Bioprinting Moment"
2.2 The COVID Factor: COVID as a Bioprinting Market Driver
2.3 The Aging Population: The Role of Bioprinting
2.4 Bioprinting, Personalized Medicine and Bringing Healthcare Closer to the Patient
2.5 New Technologies Emerge Since the Previous Bioprinting Moment
2.5.1 Challenges to Technological Advances in Bioprinting
2.6 The Growing Potential for Modeling
2.7 Impact of Government Regulation and Funding
2.8 A Broader Range of Bioinks
2.9 Ethical Concerns with Bioprinting
2.10 Key Points from this Chapter
Chapter Three: Bioprinters: Technical and Market Evolution
3.1 The Essence of a Bioprinter
3.2 Extrusion Bioprinters
3.2.1 Examples of Extrusion Bioprinters
3.2.2 The Future of Extrusion-based Bioprinting
3.3 Inkjet Bioprinters
3.3.1 Thermal Inkjet for Bioprinting
3.3.2 Piezoelectric Inkjet for Bioprinting
3.3.3 The Rastrum Bioprinter: An Example of an Inkjet Printer
3.4 Stereolithography (SLA)
3.4.1 The Problem with SLA-based Bioprinting
3.4.2 Manufacturers of SLA Bioprinters
3.5 Other Bioprinting Technologies
3.6 Ten-year Forecasts of Bioprinter Markets by Printer Technology and Printer Type
3.6.1 From Research Bioprinting to Biofabrication: A Forecast
3.7 Key Points from this Chapter
Chapter Four: Bioinks
4.1 Bioink Introductory
4.1.1 Scaffold-based and Scaffold-free Bioprinting
4.1.2 Hydrogels
4.1.3 Stem Cells and Bioprinting
4.1.4 Spheroids and Organoids
4.1.5 Ceramics and Bioprinting
4.1.6 A Note on Shear Printing
4.2 Types of Bioinks: Functionality
4.2.1 Sacrificial Bioinks
4.2.2 Functional Bioinks
4.2.3 Support Bioinks
4.3 Materials for Bioinks
4.3.1 Agarose
4.3.2 Alginate
4.3.3 Collagen
4.3.4 Gelatin
4.3.5 GelMA
4.3.6 Chitosan
4.3.7 Hyaluronic Acid
4.3.8 dECM
4.3.9 Fibrin
4.3.10 Cellulose
4.3.11 Silk
4.3.12 Extracellular matrix (ECM)-based bioinks
4.3.13 Role of Synthetic Polymers
4.3.14 Smart Bioinks and Bioinks with Advanced Material Additives
4.4 Phasing out Animal Materials
4.5 Bioink Supply Chain and Suppliers
4.6 Key Points from this Chapter
Chapter Five: Mainstream Bioprinting Applications
5.1 Bioprinting Applications Analysis: Introductory
5.2 Bioprinting and Improved Medical Modeling
5.2.1 Organs-on-a-chip
5.2.2 Disease Modeling
5.3 Bioprinting Skin
5.3.1 Background to Skin Grafting
5.3.2 Bioprinting and Burn Victims
5.3.3 Bioinks for Skin Bioprinting
5.3.4 Cosmetics Testing
5.4 Bone and Cartilage Printing
5.4.1 Materials for Bone and Cartilage Printing
5.5 Organ Printing and Vascular Printing
5.5.1 Competition Between Printed Organs and Living Organs
5.5.2 Bladder Printing
5.5.3 Bioprinting and Breast Implants
5.5.4 Liver Printing
5.5.5 Endocrine System
5.5.6 A Printed Pancreas
5.5.7 Kidney Bioprinting
5.5.8 Lungs
5.5.9 Ears and Noses
5.5.10 Eyes
5.5.11 Hearts and Vasculature
5.5.12 Bioprinting and Neural Tissue
5.6 A Note on Dental Applications of Bioprinting
5.7 Key Points from this Chapter
Chapter Six: New Directions in Bioprinting
6.1 Introduction
6.2 Soft Robotics
6.2.1 Soft Robotics and Printing Using Biological Materials
6.3 Food Printing
6.3.1 Drivers for Food Printing
6.3.2 Food Printers and Food Design
6.3.3 Food Printers Currently Available
6.3.4 Bioprinting Meat
6.3.5 Printing Candies and Chocolates
6.3.6 3D Printing-Themed Restaurants
6.4. Pill Printing
6.4.1 Manufacturing of Pills Using 3D Printing: Advantages and Disadvantages
6.4.2 Structure of a Growing Industry
6.5 A Note on Medical Devices
6.6 Key Points from this Report
Chapter Seven: Profiles of Nine Leading Bioprinting Firms and Their Strategies
7.1 Criteria for Profiling
7.2 3DBio Therapeutics: Full Bioprinting Package for Healthcare Providers
7.3 3D Systems/Systemic Bio: Still Feeling its Way in the Bioprinting Business?
7.4 BICO (Cellink): Bioconvergence Conglomerate
7.5 Cyfuse - Japanese Bioprinting Firm
7.6 EnvisionTEC/Desktop Metal: More Interest in Bioprinting
7.7 FluidForm - Building Ties to Important Companies with Cutting Edge Technology
7.8 Inventia Life Science: Breaking Out from R&D
7.9 Organovo Holdings: More Focus Than Before
7.10 Rokit Healthcare - Korean Bioprinting and Google Cloud
About the Analyst
For more information about this report visit https://www.researchandmarkets.com/r/14r493
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-bioprinting-markets-and-opportunities-report-2022-how-the-major-bioprinting-companies-are-designing-their-marketing-strategies-to-take-their-share-of-the-1-2-billion-industry-301713423.html
SOURCE Research and Markets
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
Quantum Art Raises $100 Million in Series A Round to Drive Scalable, Multi-Core Quantum Computing | Jan 22, 2026
|
|
TESSAN to Redefine Global Mobility at CES 2026 with '100 Travelers' Initiative and Flagship Voyager 205 | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
1inch Named Exclusive Swap Provider at Launch for Ledger Multisig | Jan 22, 2026
|
|
|
